Preclinical evaluation of multivalent vaccine combinations against Shigella and Salmonella infections
antigens, has the potential to enhance vaccine acceptance and uptake, facilitate programmatic roll-out, reduce delivery costs, and contribute to reducing disease burden and antimicrobial resistance.
Authors
- Francesco Berlanda Scorza (ORCID: https://orcid.org/0000-0003-2307-7855)
- Renzo Alfini
- Carlo Giannelli (ORCID: https://orcid.org/0000-0002-6112-6841)
- Francesca Micoli (ORCID: https://orcid.org/0000-0001-8243-3181)
- Francesca Mancini (ORCID: https://orcid.org/0000-0003-2122-9480)
- Valentina Caradonna (ORCID: https://orcid.org/0000-0003-3092-125X)
- Paola Cescutti (ORCID: https://orcid.org/0000-0003-3744-2198)
- Martina Carducci
- Rebecca Nappini
- Federica Boretto
- Salvatore Gemmellaro
- Roberta Di Benedetto
- Simona Rondini
- Omar Rossi
Institutions
- University of Trieste (IT)
- Global Vaccines (United States) (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-04-22
- DOI
- https://doi.org/10.3389/fimmu.2026.1807547
- Primary Topic
- Salmonella and Campylobacter epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00